Mark Goodman insider trades: Interpharm Holdings (IPA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 5, 2005 | IPA | ↑ Buy | 10,000 | $1.55 | $16K | Direct | Aug 8, 2005 (3d) |
| Jul 28, 2005 | IPA | ↑ Buy | 7,600 | $1.65 | $13K | Direct | Jul 28, 2005 (0d) |
| Jul 21, 2005 | IPA | ↑ Buy | 10,000 | $1.60 | $16K | Direct | Jul 22, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark Goodman's insider trades
Mark Goodman is a director at Interpharm Holdings (IPA). Since Jul 21, 2005, Mark has reported 3 open-market purchases worth $44K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IPA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.